GH1 and obesity due to melanocortin 4 receptor deficiency: Confounding factors such as preexisting metabolic abnormalities, obesity, age, gender and the dose of rhGH therapy may affect the clinical parameters used to evaluate the efficacy of GH replacement in GHD patients [169–171].